Ferdinando Nicoletti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY	2020
Serum xanthurenic acid levels. reduced in subjects at ultra high risk for psychosis	SCHIZOPHRENIA RESEARCH	2019
Targeting mGlu receptors for optimization of antipsychotic activity and disease-modifying effect in schizophrenia	FRONTIERS IN PSYCHIATRY	2019
Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status	EXPERT OPINION ON THERAPEUTIC TARGETS	2019
Migraine and cluster headache show impaired neurosteroids patterns	THE JOURNAL OF HEADACHE AND PAIN	2019
Developmental abnormalities in cortical GABAergic system in mice lacking mGlu3 metabotropic glutamate receptors	FASEB JOURNAL	2019
Risk factors for Alzheimer's disease: focus on stress	FRONTIERS IN PHARMACOLOGY	2019
Different generations of type-b monoamine oxidase inhibitors in parkinson’s disease: From bench to bedside	CURRENT NEUROPHARMACOLOGY	2019
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia	FRONTIERS IN PSYCHIATRY	2019
Risk Factors for Alzheimer's Disease: Focus on Stress	FRONTIERS IN PHARMACOLOGY	2019
Neurobiological links between depression and AD: The role of TGF-Î²1 signaling as a new pharmacological target	PHARMACOLOGICAL RESEARCH	2018
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2018
Targeting metabotropic glutamate receptors in the treatment of primary brain tumors	CURRENT OPINION IN PHARMACOLOGY	2018
Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease	CURRENT OPINION IN PHARMACOLOGY	2018
Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system	NEUROPHARMACOLOGY	2018
Targeting mGlu5 metabotropic glutamate receptors in the treatment of cognitive dysfunction in a mouse model of phenylketonuria	FRONTIERS IN NEUROSCIENCE	2018
Stress as risk factor for Alzheimer's disease	PHARMACOLOGICAL RESEARCH	2018
Genetic rescue of absence seizures	CNS NEUROSCIENCE & THERAPEUTICS	2018
The reduction in glutamate release is predictive of cognitive and emotional alterations that are corrected by the positive modulator of AMPA receptors S 47445 in perinatal stressed rats	NEUROPHARMACOLOGY	2018
Reduced maternal behavior caused by gestational stress is predictive of life span changes in risk-taking behavior and gene expression due to altering of the stress/anti-stress balance	NEUROTOXICOLOGY	2018

Progetti di Ricerca

Trace amines and TAAR-1 receptors in the pathophysiology and experimental treatment of parkinsonism
In vivo assessment of type-5 metabotropic glutamate receptor signaling during the performance of cognitive tasks and in preclinical models of monogenic autism
Role for type-5 metabotropic glutamate receptors in the development of cortical GABAergic interneurons